Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Nature Structural & Molecular Biology|June 1, 2023
Structural basis for control of bacterial RNA polymerase pausing by a riboswitch and its ligandAdrien Chauvier, Jason C Porta, Indrajit Deb, et al.
Medical Oncology (Northwood, London, England)|July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreementC Porta, G Tortora, C Linassier, et al.
Hepato-Gastroenterology|March 13, 1998
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port systemM Alessiani, L Vai, V Jemos, et al.
Toxicon : Official Journal of the International Society on Toxinology|July 5, 2020
In vivo effects of the association of the psychoactive phenotiazine thioridazine on antitumor activity and hind limb paralysis induced by the native polypeptide crotamineLucas C Porta, Joana D Campeiro, Giovanna B Papa, et al.
International Nursing Review|June 3, 2020
Nursing practice and global refugee migration: initial impressions from an Intergovernmental-Academic PartnershipV Bampoh, M Thongkhamkitcharoen, S Dicker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2001
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesotheliomaP Cacciotti, R Libener, P Betta, et al.
Pageof 19